Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells-Reference-Cited by-同舟云学术

Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells

Published:2009-05-27 Issue:5 Volume:4 Page:e5715
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Drecoll Enken,Gaertner Florian C.,Miederer Matthias,Blechert Birgit,Vallon Mario,Müller Jan M.,Alke Andrea,Seidl Christof,Bruchertseifer Frank,Morgenstern Alfred,Senekowitsch-Schmidtke Reingard,Essler Markus

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Tumor therapy with targeted atomic nanogenerators.;MR McDevitt;Science,2001

2. Realizing the potential of the Actinium-225 radionuclide generator in targeted α-particle therapy applications.;M Miederer;Adv Drug Deliv Rev,2008

3. Targeted actinium-225 in vivo generators for therapy of ovarian cancer.;PE Borchardt;Cancer Res,2003

4. Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using ¹⁴⁹Tb-rituximab.;GJ Beyer;Eur J Nucl Med Mol Imaging,2004

5. Radioimmunotherapy of human colon carcinoma xenografts using a ²¹³Bi-labeled domain-deleted humanized monoclonal antibody.;D Milenic;Cancer Biother Radiopharm,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha-Emitting Radionuclides: Current Status and Future Perspectives;Pharmaceuticals;2024-01-08

2. Alpha Particle–Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery;Molecular Imaging and Biology;2023-10-16

3. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery;MOL IMAGING BIOL;2023

4. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review);International Journal of Molecular Medicine;2023-07-21

5. Harnessing Oncolytic Extracellular Vesicles for Tumor Cell‐Preferential Cytoplasmic Delivery of Misfolded Proteins for Cancer Immunotherapy;Small;2023-05-24